J Parsonnet

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Fecal and oral shedding of Helicobacter pylori from healthy infected adults
    J Parsonnet
    Department of Medicine, School of Medicine, Stanford University, Calif 94305 5405, USA
    JAMA 282:2240-5. 1999
  2. ncbi request reprint Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology
    M F Rupnow
    Department of Engineering Economic Systems and Operations Research, Stanford University, CA, USA
    Helicobacter 4:272-80. 1999
  3. ncbi request reprint Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
    M F Rupnow
    Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, USA
    Vaccine 20:879-85. 2001
  4. ncbi request reprint Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
    J Parsonnet
    Department of Medicine, Stanford University School of Medicine, CA 94305, USA
    Lancet 348:150-4. 1996
  5. pmc Bacterial infection as a cause of cancer
    J Parsonnet
    Department of Medicine, Stanford University School of Medicine, California, USA
    Environ Health Perspect 103:263-8. 1995
  6. doi request reprint Helicobacter pylori and gastric adenocarcinoma
    V Herrera
    Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Clin Microbiol Infect 15:971-6. 2009
  7. pmc Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities
    C Pepperell
    Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, California 94305 5323, USA
    Int J Tuberc Lung Dis 15:899-905. 2011
  8. pmc Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta)
    J V Solnick
    Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California 95616, USA
    Infect Immun 69:6887-92. 2001
  9. pmc A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States
    M F Rupnow
    Stanford University, Stanford, California, USA
    Emerg Infect Dis 6:228-37. 2000
  10. ncbi request reprint Epidemiology of sepsis syndrome in 8 academic medical centers
    K E Sands
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass, USA
    JAMA 278:234-40. 1997

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Fecal and oral shedding of Helicobacter pylori from healthy infected adults
    J Parsonnet
    Department of Medicine, School of Medicine, Stanford University, Calif 94305 5405, USA
    JAMA 282:2240-5. 1999
    ..Helicobacter pylori commonly infects humans; however, its mode of transmission remains unknown...
  2. ncbi request reprint Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology
    M F Rupnow
    Department of Engineering Economic Systems and Operations Research, Stanford University, CA, USA
    Helicobacter 4:272-80. 1999
    ..We evaluated the cost-effectiveness (CE) of H. pylori vaccine development and use in the United States and developing countries, using a method developed by the Institute of Medicine (IOM)...
  3. ncbi request reprint Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
    M F Rupnow
    Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, USA
    Vaccine 20:879-85. 2001
    ..Helicobacter pylori vaccines, which have been suggested as promising interventions to control infection, are under development. We sought to quantify the potential population impact of a prophylactic H. pylori vaccine...
  4. ncbi request reprint Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
    J Parsonnet
    Department of Medicine, Stanford University School of Medicine, CA 94305, USA
    Lancet 348:150-4. 1996
    ....
  5. pmc Bacterial infection as a cause of cancer
    J Parsonnet
    Department of Medicine, Stanford University School of Medicine, California, USA
    Environ Health Perspect 103:263-8. 1995
    ..Because bacterial infections can be cured with antibiotics, identification of bacterial causes of malignancy could have important implications for cancer prevention...
  6. doi request reprint Helicobacter pylori and gastric adenocarcinoma
    V Herrera
    Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Clin Microbiol Infect 15:971-6. 2009
    ..This article reviews the current knowledge on H. pylori and gastric cancer and presents some of the clinical and public health challenges associated with this pathogen...
  7. pmc Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities
    C Pepperell
    Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, California 94305 5323, USA
    Int J Tuberc Lung Dis 15:899-905. 2011
    ..Average tuberculosis (TB) incidence rates are high in Canadian Aboriginal communities, but there is significant variability within this group...
  8. pmc Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta)
    J V Solnick
    Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, California 95616, USA
    Infect Immun 69:6887-92. 2001
    ..pylori vaccination...
  9. pmc A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States
    M F Rupnow
    Stanford University, Stanford, California, USA
    Emerg Infect Dis 6:228-37. 2000
    ..pylori has decreased to values so low that, should this trend continue, the organism will disappear from the population without targeted intervention; this process, however, will take more than a century...
  10. ncbi request reprint Epidemiology of sepsis syndrome in 8 academic medical centers
    K E Sands
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass, USA
    JAMA 278:234-40. 1997
    ..Sepsis syndrome is a leading cause of mortality in hospitalized patients. However, few studies have described the epidemiology of sepsis syndrome in a hospitalwide population...
  11. doi request reprint The impact of mucosal infections on acquisition and progression of tuberculosis
    S Perry
    Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
    Mucosal Immunol 4:246-51. 2011
    ..Understanding how the complexity of microbial exposures influences host immunity may have important implications for vaccine development and therapeutic interventions...
  12. ncbi request reprint Helicobacter pylori and risk for gastric adenocarcinoma
    R J Asghar
    Department of Medicine, Stanford University School of Medicine, CA, USA
    Semin Gastrointest Dis 12:203-8. 2001
    ..pylori infection in individuals with family histories of gastric malignancy. In high-risk countries, screening programs for early gastric cancer itself may improve therapeutic outcome for this highly lethal disease...